Transitional CXCL14+ cancer‐associated fibroblasts enhance tumour metastasis and confer resistance to EGFR‐TKIs, revealing therapeutic vulnerability to filgotinib in lung adenocarcinoma.
Saved in:
| Title: | Transitional CXCL14+ cancer‐associated fibroblasts enhance tumour metastasis and confer resistance to EGFR‐TKIs, revealing therapeutic vulnerability to filgotinib in lung adenocarcinoma. |
|---|---|
| Authors: | Xu, Weijiao1 (AUTHOR), Yang, Haitang1 (AUTHOR) haitang.yang@shsmu.edu.cn, Xu, Ke1 (AUTHOR), Zhu, Anshun2 (AUTHOR), Hall, Sean R. R.3,4 (AUTHOR), Jia, Yunxuan1 (AUTHOR), Zhao, Baicheng1 (AUTHOR), Zhang, Enshuo1 (AUTHOR), Liu, Gang1 (AUTHOR), Xu, Jianlin5 (AUTHOR), Marti, Thomas M.3,4 (AUTHOR), Peng, Ren‐Wang3,4 (AUTHOR), Dorn, Patrick3,4 (AUTHOR), Niu, Yongliang6 (AUTHOR), Pan, Xufeng1 (AUTHOR) panxfshch@163.com, Zhang, Yajuan7 (AUTHOR) zhangyajuan2013@sibcb.ac.cn, Yao, Feng1,2 (AUTHOR) yaofeng@shsmu.edu.cn |
| Source: | Clinical & Translational Medicine. Apr2025, Vol. 15 Issue 4, p1-25. 25p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
